<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01731340</url>
  </required_header>
  <id_info>
    <org_study_id>GEN-11-231</org_study_id>
    <nct_id>NCT01731340</nct_id>
  </id_info>
  <brief_title>A Study on the Impact of Calcium on Woman's Vascular Health</brief_title>
  <official_title>The Effect of Dietary Calcium Intake as Compared to Calcium Supplementation on Vascular Health and Bone Health in Postmenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Centre/Research Institute of the McGill University Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Centre/Research Institute of the McGill University Health Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching aim of this randomized clinical trial is to estimate the effect of dietary&#xD;
      intake of calcium as compared to supplemental calcium on the vascular system and markers of&#xD;
      vascular and bone health in postmenopausal women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Calcium and vitamin D are essential nutrients for optimal bone health throughout life.&#xD;
      Research has shown that postmenopausal women who consume appropriate amounts of these&#xD;
      nutrients have better bone strength and fewer fractures than those who don't. However,&#xD;
      researchers have recently questioned the safety of calcium and vitamin D obtained through&#xD;
      supplements as they might increase the risk of cardiovascular events such as heart attacks&#xD;
      and strokes.&#xD;
&#xD;
      The investigators propose to estimate the effect of dietary intake of calcium as compared to&#xD;
      supplemental calcium on vascular and bone health in postmenopausal women.&#xD;
&#xD;
      Eligible participants will be assigned by chance (like a coin toss) to one of three groups:&#xD;
      (1) 1200 mg of calcium from dietary sources and 1 capsule of 400 IU vitamin D supplement&#xD;
      everyday after the first meal of the day; (2) 450 mg of calcium from dietary sources, 2&#xD;
      tablets of 250 mg calcium citrate supplement and 1 capsule of 800 IU vitamin D supplement&#xD;
      everyday after the first meal of the day and 1 tablet of 250 mg calcium citrate supplement&#xD;
      after the evening meal or snack; or (3) unrestricted calcium from dietary sources and 1&#xD;
      capsule of 400 IU vitamin D supplement everyday after the first meal of the day. Participants&#xD;
      have an equal chance of being assigned to any of these three groups until 26 participants&#xD;
      have been assigned to group (3). At this time participants will continue to be assigned by&#xD;
      chance to either of the two remaining groups only.&#xD;
&#xD;
      Participants will also attend appointments at the Montreal General Hospital every 6-months&#xD;
      where they will undergo anthropometric measurements, blood tests, urine tests, non-invasive&#xD;
      ultrasounds to measure arterial stiffness and questionnaires. The questionnaires ask about&#xD;
      health; lifestyle habits such as physical exercise, diet, and smoking; use of medications and&#xD;
      dietary supplements; family history of illness, and past medical diagnoses. Participants will&#xD;
      also receive monthly phone calls from study staff to monitor for adverse events and&#xD;
      adherence.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2012</start_date>
  <completion_date type="Actual">November 14, 2018</completion_date>
  <primary_completion_date type="Actual">November 14, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular System</measure>
    <time_frame>12 months</time_frame>
    <description>Measured as changes in:&#xD;
Arterial stiffness (carotid-femoral pulse wave velocity)&#xD;
Arterial wall thickness (carotid intima-media thickness)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>12 Months</time_frame>
    <description>Measured as changes in:&#xD;
- Peripheral blood pressure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Blood Biomarkers</measure>
    <time_frame>12 months</time_frame>
    <description>Measured as changes in:&#xD;
Vascular health biomarkers&#xD;
Bone health biomarkers</description>
  </other_outcome>
  <other_outcome>
    <measure>Anthropomorphic measurements</measure>
    <time_frame>12 months</time_frame>
    <description>Measured as changes in bone health biomarkers.&#xD;
Body mass index&#xD;
Waist circumference&#xD;
Body fat %</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>Occurrence of cardiovascular, cerebrovascular and renal events as well as fractures and intolerance to interventions.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Supplemental Calcium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>750 mg Calcium Citrate per day&#xD;
800 IU Vitamin D3 per day&#xD;
Low Dietary Calcium (450 mg per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Calcium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400 IU Vitamin D3 per day&#xD;
High Dietary Calcium (1200 mg per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>400 IU Vitamin D3 per day&#xD;
Unrestricted Dietary Calcium</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium Citrate</intervention_name>
    <description>750mg</description>
    <arm_group_label>Supplemental Calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Dietary Calcium</intervention_name>
    <description>450 mg</description>
    <arm_group_label>Supplemental Calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Dietary Calcium</intervention_name>
    <description>1200 mg</description>
    <arm_group_label>Dietary Calcium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged 50 or more&#xD;
&#xD;
          -  2 years since last menstrual period&#xD;
&#xD;
          -  Body Mass Index between 20 and 35 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Atrial Fibrillation&#xD;
&#xD;
          -  Coronary artery disease&#xD;
&#xD;
          -  Myocardial infarction&#xD;
&#xD;
          -  Stroke&#xD;
&#xD;
          -  Transient ischaemic attack&#xD;
&#xD;
          -  Peripheral vascular disease&#xD;
&#xD;
          -  Sleep apnea&#xD;
&#xD;
          -  Hypertension&#xD;
&#xD;
          -  Hyperlipidemia&#xD;
&#xD;
          -  Hyperparathyroidism&#xD;
&#xD;
          -  Urinary tract lithiasis&#xD;
&#xD;
          -  Rheumatoid arthritis&#xD;
&#xD;
          -  Crohn's disease&#xD;
&#xD;
          -  Ulcerative colitis&#xD;
&#xD;
          -  Short gut syndrome&#xD;
&#xD;
          -  Celiac disease&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Cancer (any other than basal cell cancer of the skin)&#xD;
&#xD;
          -  Pre-eclampsia&#xD;
&#xD;
          -  Smoked in the last 5 years&#xD;
&#xD;
          -  Cocaine use in the last year&#xD;
&#xD;
          -  Consumption of more than 9 alcoholic drinks per week&#xD;
&#xD;
          -  Chronic NSAID use&#xD;
&#xD;
          -  Use of oral glucocorticoids or HRT (excluding vaginal preparations) in the last 2&#xD;
             years&#xD;
&#xD;
          -  Use of anti-osteoporosis medications (bisphosphonates, selective estrogen-receptor&#xD;
             modulators, denosumab, teriparatide, or calcitonin) in the last 3 years or&#xD;
             anti-osteoporosis therapy which ended more than 3 years ago and whose duration was â‰¥ 5&#xD;
             years, or a fracture of the spine, shoulder, or hip was sustained while therapy&#xD;
&#xD;
          -  Use of calcium and vitamin D supplements (including multivitamins and&#xD;
             calcium-containing antacids) in the last 2 months&#xD;
&#xD;
          -  High 10-year probability of major osteoporotic fracture (FRAX without BMD &gt; 20%)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne Morin, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Hospital Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Internal Medicine; Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>November 16, 2012</study_first_submitted>
  <study_first_submitted_qc>November 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2012</study_first_posted>
  <last_update_submitted>September 16, 2019</last_update_submitted>
  <last_update_submitted_qc>September 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Centre/Research Institute of the McGill University Health Centre</investigator_affiliation>
    <investigator_full_name>Suzanne Morin</investigator_full_name>
    <investigator_title>MD MSc FRCP</investigator_title>
  </responsible_party>
  <keyword>Calcium Supplements</keyword>
  <keyword>Dairy Foods</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>Postmenopause</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Micronutrients</keyword>
  <keyword>Primary Prevention</keyword>
  <keyword>Bone Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

